Delivery Order SPE2DB20D1110-SPE2DB24FK53V
Award Date
9/16/24
Potential Completion Date
9/17/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,634.00 firm-fixed-price delivery order is for the supply of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets in 120-count packages. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,877.76 firm fixed-price delivery order is for the supply of 120 units of the pharmaceutical product Alfuzosin HCL Extended-Release 10 mg Tablets. The contract has an ultimate completion date of August 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $4,677.91, is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a $1,251.84 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4565114944 - Alfuzosin HCL ER 10 mg Tablets, 120 count, with a completion date of July 12, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with various federal agencies, including the...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets in packages of 90. The contract has a firm fixed price of $4,206.45 and an ultimate completion date of September 25, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is not a set-aside and is a delivery order under a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.48 delivery order contract is for the supply of Alfuzosin HCL ER 10 mg tablets, and has a period of performance through October 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.40 fixed-price delivery order contract is for the supply of 90-count bottles of 10 mg Alfuzosin HCl extended-release tablets. The contract has a period of performance through March 26, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.77, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,644.03, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed price delivery order contract with an ultimate completion date of January 27, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,325,624 units of the prescription medication Alfuzosin HCl ER 10 mg Tablet. The $2,421.58 firm fixed price contract has a period of performance through April 19, 2024 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...